Dr. Robert Walter Kopp II, MD

Dr. Kopp practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Kopp's NPI, 1487913794, was assigned on May 7, 2012. Dr. Kopp graduated from SUNY Upstate Medical University in 2012. Dr. Kopp holds Florida license ME131112.

Dr. Kopp's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Kopp's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Kopp is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Kopp to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kopp practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kopp's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kopp is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Kopp is licensed in Florida.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and tinnitus among the conditions Dr. Kopp treats.

CMS data shows 2,997 Medicare services from Dr. Kopp across 20 procedure codes in 2024, for 664 Medicare patients. Medicare paid $518,027 for them.

CMS counts 664 Medicare patients who saw Dr. Kopp in 2024. The largest group is 65 to 74, with 302 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kopp's median patient age at 70, with 52% women.

In 2024, Dr. Kopp wrote 1,588 Medicare Part D claims for 527 patients. 97% of them were for generic drugs. CMS names the drug for 1,480 of them, across 17 drugs with 11 or more claims each, at $30,360 in total drug cost. In 2023, CMS named 1,546 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kopp for performance year 2024, reported individually. Dr. Kopp accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Kopp, published from 2011 to 2015. The most frequent topics are Mandibular Fractures. Dr. Kopp's most frequent co-authors are Parul Goyal, MD, Parul M. Goyal, MD and Tucker Martin Harris, MD.

CMS Open Payments shows 88 general payments to Dr. Kopp from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Entellus Medical, Inc. paid the most, $1,863.

Dr. Kopp graduated from SUNY Upstate Medical University in 2012.

Dr. Kopp is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.